Tightening oversight of notified bodies: enough to satisfy critics?
This article was originally published in Clinica
Executive Summary
With notified body activities very much in the spotlight throughout 2009 following the suggestions of radical changes in their role in the European Commission’s proposed recast document last year, the progress report from the Notified Body Operations Group (NBOG) makes crucial reading for anyone concerned about the future medtech regulatory system.
You may also be interested in...
EU Regulatory Experts Support Notified Bodies, But Argue For Greater Consistency
Notified bodies have been a pivotal part of the EU medtech regulatory system since it was first launched in the 1990s. Where might they fit within a new medtech regulatory governance structure? Panelists on a recent vodcast grappled with the question.
First Public Discussion On How EU Medtech Regulatory Governance Structure May Evolve
Does the EU need a medtech agency for the first time in its history? Nothing can or should be decided too quickly but five high-profile experts broadly agreed that change is now critical.
First Danish Notified Body Named Under EU's Medical Device Regulation
The EU now has a total of 45 notified bodies under the MDR.